Australia's most trusted
source of pharma news
Tuesday, 5 May 2026
Tuesday, 5 May 2026
Subscribe
Login
What happened to the PBS in Q1?
There was a massive drop in reported earnings on the PBS in the first quarter of this year, with the Department of Health providing no clear explanation as to the cause.
Lilly GM confirms drug launch
Newly approved treatment soon to roll out on private script with Aussie boss acknowledging the "significant challenges" in securing subsidy
TODAY
PBS increase to strain Budget
Govt foreshadows that increased spending on subsidising pharmaceuticals will be the third greatest pressure on the Budget
TODAY
Why pharma hires are quitting
Onboarding at Aussie pharma companies is failing to create emotional attachment to work driving new hires to quit
4 May
Who's made a move to new digs?
While marking a milestone in Australia, this pharma is focused on the future with a long-term commitment to collaboration and innovation
4 May
Who's won an MA Board seat?
After 10 Country Leaders put up their hand to join the Board of industry peak body, these four made the cut
1 May
Aussie pharma on the nose
Industry's approval rating among patients fell nine per cent, one of the worst global results but not everyone's in the bad books
1 May
Latest Jobs
Customer Service Team LeaderRegulatory Submissions SpecialistTerritory ManagerTrade Marketing ManagerProduct ManagerInternal Communications SpecialistStorepersonSenior Medical Manager24 more...
Pharma in Focus Jobs
Marketing & Communications (8)
- Trade Marketing Manager - Sydney
- Product Manager - New South Wales
- Internal Communications Specialist - Melbourne
- Trade Marketing Manager - Sydney
- Senior Product Manager - Sydney
- Associate Marketing Manager - OTC - Sydney
- Senior Data & Insights Analyst - Melbourne
- Data & Insights Analyst - Melbourne
Sales & Customer Relations (10)
- Customer Service Team Leader - Frenchs Forest
- Territory Manager - Melbourne
- Territory Manager - Surgical - Sydney
- Pharmaceutical Sales Representative - Sydney
- Account Manager - Sydney
- Senior Territory Manager - Melbourne
- Customer Service Lead - Frenchs Forest
- Customer Service Representative - St Leonards
- Customer Service Specialist - Frenchs Forest
- Customer Service Representative - East Ryde
Clinical & Medical, R&D (6)
- Senior Medical Manager - Melbourne
- Senior Medical Science Liaison - Melbourne
- Clinical Trial Start Up Specialist - Melbourne
- Clinical Project Manager - Oncology - Sydney, NSW
- Senior Manager, Clinical Operations (Japan) - Tokyo, Japan
- Clinical Trials Investigator - Melbourne
Regulatory, Pharmacovigilance & QA (3)
- Regulatory Submissions Specialist - Melbourne
- QA Specialist - Melbourne
- Senior Regulatory Affairs Associate - Sydney
Executive Roles (1)
Other (6)
Aussie discovery goes commercial
First-in-class drug developed from local research has been TGA approved, with the sponsor "exploring" PBS reimbursement
4 May
Blast from the past heads to PBAC
A treatment deferred four years ago is back on the agenda, along with a cancer drug that was marked 'ceased' at the start of April
4 May
siRNA specialist enters Aust market
TGA approves first-in-class siRNA therapeutic, a new brand of Eisai's kinase inhibitor, plus a long list of generics of PBS listed drugs
4 May Approvals Action
Drought strikes May PBS listings
PBS listings have dried up with only three additions to the scheme this month. Find out who won a May listing...
1 May New to the PBS
New Top 25 Big Pharma is born
ICYMI: The buyout of Organon by Sun Pharma will create a new top-ranking pharma plus the other most popular stories this week
1 May Your Week in 5 Minutes
Rising cost of PBAC submissions
Department releases its proposed fee structure for the processes of listing on the PBS, and just how much it expects to raise
1 May
Which CAR T saved Sam Neill?
An experimental therapy has eliminated Neill's cancer, with the actor describing himself as 'patient zero' for the new treatment
30 April
High-flyers on the move in pharma
Top-level appointments announced including one executive who has switched between the same two companies over eight years
30 April
First May PBS listing goes to...
Cancer drug reimbursement win underlines the company's "ongoing investment in oncology" GM says, providing patients more choice
1 May
TGA eyes five new drug filings
Regulatory pathways handed out by the TGA signals five new drugs are on the cusp of being filed in the coming months, if not sooner
30 April
10-drug ANZ deal sealed
Exclusive commercial and licensing agreement could pave the way for 10 injectable, oral, and speciality drugs to be launched in ANZ
30 April
Next up: Ozempic pills for kids
Novo chases another first, aiming to file for a label expansion in the US and EU for oral semaglutide to treat T2 diabetes in kids and teens
30 April
New GM calls out PBS wait times
Miniscule decline in wait time between TGA approval and PBS listing is nowhere near good enough, new Country Leader warns
29 April
Pharma off target, doctors say
Industry's concerted efforts to meaningfully engage with Australian doctors seems to be missing the mark
29 April